|
| 36725887 | Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth. | Oncogene | 2023 |
| 37550801 | ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression. | J Pathol | 2023 |
| 37607794 | Use of artificial intelligence in the detection of primary prostate cancer in multiparametric MRI with its clinical outcomes: a protocol for a systematic review and meta-analysis. | BMJ Open | 2023 |
| 37769532 | Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts. | Eur J Radiol | 2023 |
| 35414034 | Diagnostic potential of radiological apical tumor involvement. | J Robot Surg | 2023 |
| 36855895 | Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging. | BJU Int | 2023 |
| 36810476 | Joint estimation of relaxation and diffusion tissue parameters for prostate cancer with relaxation-VERDICT MRI. | Sci Rep | 2023 |
| 36511804 | Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial. | Radiology | 2023 |
| 34799996 | Effects of photobiomodulation therapy on regulation of myogenic regulatory factor mRNA expression in vivo: A systematic review. | J Biophotonics | 2022 |
| 35885536 | Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion Models. | Diagnostics (Basel) | 2022 |
| 35884558 | Comparison of Multiparametric Magnetic Resonance Imaging with Prostate-Specific Membrane Antigen Positron-Emission Tomography Imaging in Primary Prostate Cancer Diagnosis: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2022 |
| 35916679 | Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study. | Radiology | 2022 |
| 34987040 | Relationship of prostate cancer topography and tumour conspicuity on multiparametric magnetic resonance imaging: a protocol for a systematic review and meta-analysis. | BMJ Open | 2022 |
| 33185024 | Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still out. | BJU Int | 2021 |
| 33823175 | Patient Perspectives and Understanding of MRI-directed Prostate Cancer Diagnosis. | Urology | 2021 |
| 33924255 | Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial. | Cancers (Basel) | 2021 |
| 34893484 | Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis. | BMJ Open | 2021 |
| 34586984 | Micro-ultrasound vs. MRI for prostate cancer diagnosis: Considerations to address (Re: Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer, CUAJ, Jan 2021). | Can Urol Assoc J | 2021 |
| 33958731 | Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models. | Prostate Cancer Prostatic Dis | 2021 |
| 34059394 | Mapping Contemporary Biopsy Zones to Traditional Prostatic Anatomy: The Key to Understanding Relationships Between Prostate Cancer Topography, Magnetic Resonance Imaging Conspicuity, and Clinical Risk. | Eur Urol | 2021 |
| 33980983 | The oncological relevance of fragile sites in cancer. | Commun Biol | 2021 |
| 33952556 | Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy. | BMJ Open | 2021 |
| 34337543 | Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study. | Eur Urol Open Sci | 2021 |
| 33375994 | A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological Research. | Eur Urol | 2021 |
| 33278459 | Prostate Cancer Undetected by mpMRI: Tumor Conspicuity is Reliant Upon Optimal Scan Timing and Quality. | Urology | 2021 |
| 33051065 | False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS. | Eur Urol | 2021 |
| 31600865 | Genetic correlates of prostate cancer visibility (and invisibility) on multiparametric magnetic resonance imaging: it's time to take stock. | BJU Int | 2020 |
| 31992607 | Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis. | BMJ Open | 2020 |
| 31941506 | Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: a case report. | BMC Cancer | 2020 |
| 33033409 | Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype. | Commun Biol | 2020 |
| 33057024 | A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists. | Sci Rep | 2020 |
| 33177621 | Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer. | Sci Rep | 2020 |
| 33093035 | Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis. | BMJ Open | 2020 |
| 33000006 | Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis. | Eur Urol Open Sci | 2020 |
| 32796921 | Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype. | Commun Biol | 2020 |
| 32676435 | Prostate cancer biology & genomics. | Transl Androl Urol | 2020 |
| 32873828 | Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer. | Sci Rep | 2020 |
| 32698715 | Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis <i>J Urol</i> 2020; doi: 10.1097/JU.0000000000001157. | J Urol | 2020 |
| 32920937 | Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross-disciplinary translational hypothesis. | FASEB J | 2020 |
| 32581342 | Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer. | Br J Cancer | 2020 |
| 32527691 | Re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol 2020;77:501-7. | Eur Urol | 2020 |
| 32150588 | An optimised saliva collection method to produce high-yield, high-quality RNA for translational research. | PLoS One | 2020 |
| 32360049 | Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. | Eur Urol | 2020 |
| 32296034 | PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer. | Signal Transduct Target Ther | 2020 |
| 32231090 | Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol. | Methods Protoc | 2020 |
| 32319152 | Prostate cancer visibility on multiparametric magnetic resonance imaging: high Gleason grade and increased tumour volume are not the only important histopathological features. | BJU Int | 2020 |
| 32370911 | What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort. | Eur Urol | 2020 |
| 30958920 | Stroma in normal and cancer wound healing. | FEBS J | 2019 |
| 31657791 | Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking. | J Vis Exp | 2019 |
| 31450747 | The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing. | Cancers (Basel) | 2019 |